COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

A Phase I Study of Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers (HART-HN)

Protocol No
IIT-AWAN-HART-HN
Principal Investigator
Musaddiq Awan
Phase
I
Summary
This project is being done to determine whether hypofractionated radiation therapy or the safe reduction of radiation treatment fractions to 10, 8, or 5, may be delivered safely in resected Head and Neck Squamous Cell Carcinoma (HNSCC) patients with intermediate pathologic risk features.
Description
Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers (HART-HN)
Participating Institutions
Drexel Town Center
Froedtert Menomonee Falls Hospital
Froedtert West Bend Hospital
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category